Insight Molecular Diagnostics Inc.
For the period ended Dec 31, 2025. Filed Mar 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 26, 2026
IMDX$2.50+0.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Loss
| Years EndedDecember 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Net loss | $(50,222) | $(60,663) |
| Foreign currency translation adjustments | 65 | (28) |
| Comprehensive loss | $(50,157) | $(60,691) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.